Description
BLOOD BANK PRODUCTS AND SERVICES FOR VISN 1
First action · last action
2020-10-01 · 2022-01-10
Transactions
2
First transaction's obligation
$2,200,000
Base + all options value (sum of deltas)
$2,089,019
Extent competed
NOT AVAILABLE FOR COMPETITION
Other than full & open authority
AUTHORIZED BY STATUTE (FAR 6.302-5(A)(2)(I))
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C24119D0003
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2020-10-01+$2,200,000= $2,200,000
- Mod P000012022-01-10-$110,981= $2,089,019
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2020-10-01 | +$2,200,000 | $2,200,000 | BLOOD BANK PRODUCTS AND SERVICES FOR VISN 1 |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-01-10 | −$110,981 | $2,089,019 | BLOOD BANK PRODUCTS AND SERVICES FOR VISN 1 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI G69LHXJ3ABL5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25226N0551 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $2,100 | FY2026 |
| 36C25226N0550 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $2,500 | FY2026 |
| 36C25226N0549 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $170 | FY2026 |
| 36C25226N0548 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $10,000 | FY2026 |
| 36C25026P0816 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $19,329 | FY2026 |
| 36C24126N0603 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $1,998,719 | FY2026 |
Other recipients under 6505 from 241-NETWORK CONTRACT OFFICE 01 (36C241) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24126P0328 | CARDINAL HEALTH 414, LLC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $999,797 | FY2026 |
| 36C24126F0121 | MCKESSON CORPORATION | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $16,333 | FY2026 |
| 36C24126F0112 | VANTIVE US HEALTHCARE LLC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $545,567 | FY2026 |
| 36C24126F0109 | BOSTON SCIENTIFIC CORP | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $304,950 | FY2026 |
| 36C24126P0199 | JUBILANT DRAXIMAGE RADIOPHARMACIES, INC. | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $94,000 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24121N0015_3600_36C24119D0003_3600 · retrieved 2026-09-26.